Stock Price Movement and Market Performance
On 01 Oct 2026, Medi Assist Healthcare Services’ share price touched an intraday low of Rs. 293.4, representing a decline of 2.99% on the day and a day-end loss of 3.22%. This price point establishes a new 52-week and all-time low for the stock, underscoring the sustained pressure it has faced in recent months. The stock has been on a consecutive six-day losing streak, cumulatively falling by 11.88% during this period.
Comparatively, the stock underperformed its insurance sector peers by 1.85% on the same day. When benchmarked against the Sensex, Medi Assist’s performance has been notably weaker: a 3.72% decline versus the Sensex’s 0.60% drop on a single day, and a 9.09% loss over the past week compared to the Sensex’s 2.09% fall.
Extended Underperformance Across Time Horizons
The stock’s underperformance extends well beyond short-term fluctuations. Over the last month, Medi Assist’s share price has declined by 13.92%, more than double the Sensex’s 6.37% fall. The three-month performance shows a sharper contrast, with the stock down 20.64% against the Sensex’s 6.34% decline. The disparity widens further over the one-year period, where Medi Assist has lost 45.77% of its value, significantly underperforming the Sensex’s 11.04% decrease.
Year-to-date figures also reflect this trend, with the stock down 36.65% compared to the Sensex’s 15.46% loss. Over longer horizons, the stock has failed to generate positive returns, registering 0.00% over three, five, and ten years, while the Sensex has delivered gains of 9.44%, 22.59%, and 158.53% respectively.
Technical Indicators Signal Bearish Momentum
Technical analysis corroborates the bearish sentiment surrounding the stock. The overall technical trend is classified as bearish, a status that has been in place since 08 Sep 2026 when the stock traded at Rs. 332.3. The stock currently trades below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating sustained downward pressure.
Key technical indicators such as MACD and Bollinger Bands are bearish on both weekly and monthly timeframes. The Relative Strength Index (RSI) currently shows no clear signal, while the KST indicator is mildly bullish, suggesting some short-term oscillations amid the broader downtrend. Immediate support is identified at the 52-week low of Rs. 293.00, with resistance levels at Rs. 324.29 (20-day moving average), Rs. 353.21 (100-day moving average), and Rs. 370.89 (200-day moving average).
Valuation and Financial Metrics
Despite the stock’s price decline, valuation metrics present a mixed picture. The price-to-earnings (P/E) ratio stands at 22 times trailing twelve months (TTM), while the price-to-book value (P/BV) ratio is 2.69 times. Enterprise value multiples include EV/EBITDA at 11.46 times and EV/EBIT at 21.61 times. The PEG ratio is relatively elevated at 3.77, reflecting the relationship between price, earnings growth, and valuation.
The stock offers a dividend yield of 0.66%, with the latest dividend declared at Rs. 2 per share and an ex-dividend date of 11 Sep 2026. The current market capitalisation classifies the company as a small-cap entity, which often entails higher volatility and sensitivity to market movements.
Financial Performance and Quality Assessment
Financially, Medi Assist Healthcare Services has demonstrated some positive trends in recent periods. The latest six-month net sales reached Rs. 478.51 crores, reflecting a growth rate of 26.11%. Profit after tax (PAT) for the same period increased to Rs. 81.12 crores. The operating profit to interest ratio is notably high at 27.28 times, indicating strong coverage of interest expenses.
Return on equity (ROE) averages 14.05%, which is moderate but considered weak relative to industry benchmarks. The company’s capital structure is rated excellent, with a low average net debt-to-equity ratio of 0.06, suggesting limited leverage. Institutional holdings are substantial at 72.66%, indicating significant participation by large investors with analytical resources.
Long-Term Growth and Quality Indicators
Over the past five years, the company has achieved a sales compound annual growth rate (CAGR) of 23.10% and an EBIT growth rate of 9.65%. Management risk is assessed as good, while growth is categorised as average. The overall quality grade is average, reflecting a company with stable fundamentals but facing valuation pressures and market headwinds.
Despite the stock’s price erosion, the company’s profits have risen by 12% over the past year, highlighting a divergence between earnings performance and market valuation. The stock trades at a discount relative to its peers’ historical valuations, with a price-to-book value of 2.7 and an ROE of 11.3 in the latest assessment.
Summary of Market Context
Medi Assist Healthcare Services’ stock has experienced a significant decline culminating in a new all-time low of Rs. 293.4 on 01 Oct 2026. The stock’s performance has lagged behind both the broader market and its sector peers across multiple time frames, with technical indicators signalling a bearish trend. While financial metrics reveal some positive aspects such as sales growth and profit increases, these have not translated into share price appreciation. The company’s valuation multiples and quality assessments reflect a complex scenario where fundamentals and market sentiment diverge.
